Healing efficacy, safety and ease of use of a thin Algostéril

Recruiting

• Conditions: Wound care; Skin and Connective Tissue Diseases

• Registration Number: ISRCTN38373718
• Lead Sponsor: es Laboratoires Brothier

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-01-19
• Last Update Posted: 27 August 2018
• Study Completion: 2019-05-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Patients with a wound that needs to be treated with thin Algostéril
2. Those who can be followed until the wound healing
3. Signed informed consent form
4. Aged 18 years and over

Exclusion Criteria

1. Pregnant women
2. Participation in another clinical trial within 30 days prior to inclusion

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of days of treatment to obtain the wound healing is assessed through clinical examination until time of wound healing (approximately 1 month).

Secondary Outcome Measures

Name	Time	Method
1. Draining efficiency evaluated by exsudate quantity and local signs of infection at the time of redressing (every 2 days maximum)<br>2. Ease of use is assessed using a scale of 1 to 4 at the time of redressing (every 2 days maximum)<br>3. Safety is assessed by recording the type and frequency of adverse events continuously throughout the study